Zurueck zur Suche

Reporte zur Charge EN5328

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

2Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
NY 1 WA 1

VAERS 2228413

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN5328

moderat
Staat
NY
Alter
78,0
Geschlecht
M
Eingang
12.04.2022
Impfdatum
13.11.2021
Beginn
18.02.2022
Tage bis Beginn
97,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute kidney injury Anticoagulant therapy Blood creatinine increased C-reactive protein increased COVID-19 COVID-19 pneumonia Chest X-ray abnormal Computerised tomogram thorax abnormal Cough Dyspnoea Dyspnoea exertional Emphysema Fatigue Glomerular filtration rate decreased Lung infiltration Pain Pneumonia Pulmonary fibrosis

Symptomtext

2/8/2022- Patient called for Covid test: cough, congested and body aches. Covid + test. 2/9/2022- Monoclonals ordered ( Sotrovimab) Benzonatate ordered for cough. Received infusion. Rheumatology advised of Covid status, hold Imuran for at least once a week or until asymptomatic. 2/14/2022-Patient notes having body aches and SOB upon exertion, O2 sat at home 95% on RA. Advised to treat symptoms, seek immediate medical attention is SOB increases. 2/18/2022- Office visit for increased difficulty breathing on exertion and fatigue. Agreed to to hospital admission. Chest xray and labs were ordered,transfered to Medical Center. 2/18/2022-Presentated to ED, with complaints of SOB upon exertion and fatigue. 2/18/2022 Additional information for Item 18: Admitted with Acute Covid multilobar pneumonia without hypoxemic respiratory failure and mild AKI. Afebrile, HR-93, RR-18 o2 sat 97% on RA. CXR -Bilateral pulmonary infiltrates not visualized previously. Chest Ct w/o contrast- bilateral multi lobar multifocal pulmonary infiltrates , emphysema with underlying fibrosis. IV Ceftriaxone, IV Azithromycin and IV Vancomycin ordered (given in ED) . WBC -13, CRP 21.3, creatnine 1.7 and EGFR 45. On Bactrim for PCP prophylaxis, Lovenox, IV Cefepime , inhaled tobryamycin and IV doxycycline ordered. Remdesivir held due to AKI. 2/19/2022- CT chest pulmonary embolism w IV contrast patient is high risk: No evidence of PE. EGFR now >60, WBC trending down-Pulmonary added Solu-medrol. 2/20/2022- CRP-16.7. Continue with Lovenox for another 24 hours and then transition to Eliquis. Vitals WNL no supplemental oxygen needed. 2/21/2022- WBC 7.5 and Creatnine 1.0.Vitals WNL. Start Prednisone and d/c Solu-medrol. Continue current medications. Discharged to home.

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19 pneumonia
Hospital-Tage
3,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Hypertension, Granulomatosis with polyangiitis, macrocytosis , Chronic immunosuppressive medications
Andere Medikamente
-
Allergien
Albuterol
Vorherige Impfungen
-

VAERS 1058472

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN5328

moderat
Staat
WA
Alter
52,0
Geschlecht
F
Eingang
26.02.2021
Impfdatum
06.02.2021
Beginn
06.02.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Hypoaesthesia Hypoaesthesia oral Tachycardia

Symptomtext

Numbness in jaw, lips, neck on left side. Tachycardia

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tachycardia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Levothyroxine
Allergien
Amoxacillin Erythromycin Sulfa - anaphylaxis Cyclobenzaprine
Vorherige Impfungen
-